SKIN vs. PLSE, NVRO, OSUR, HLLY, OFIX, ANIK, SRDX, NPCE, BVS, and IRMD
Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include Pulse Biosciences (PLSE), Nevro (NVRO), OraSure Technologies (OSUR), Holley (HLLY), Orthofix Medical (OFIX), Anika Therapeutics (ANIK), Surmodics (SRDX), NeuroPace (NPCE), Bioventus (BVS), and Iradimed (IRMD).
Beauty Health (NASDAQ:SKIN) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation, community ranking and profitability.
In the previous week, Beauty Health had 21 more articles in the media than Pulse Biosciences. MarketBeat recorded 22 mentions for Beauty Health and 1 mentions for Pulse Biosciences. Beauty Health's average media sentiment score of 0.83 beat Pulse Biosciences' score of 0.00 indicating that Beauty Health is being referred to more favorably in the media.
Pulse Biosciences has a net margin of 0.00% compared to Beauty Health's net margin of -25.65%. Beauty Health's return on equity of -18.85% beat Pulse Biosciences' return on equity.
Pulse Biosciences received 208 more outperform votes than Beauty Health when rated by MarketBeat users. Likewise, 65.17% of users gave Pulse Biosciences an outperform vote while only 49.37% of users gave Beauty Health an outperform vote.
Beauty Health has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500.
Beauty Health presently has a consensus target price of $6.50, indicating a potential upside of 100.62%. Given Beauty Health's higher probable upside, equities research analysts clearly believe Beauty Health is more favorable than Pulse Biosciences.
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are held by institutional investors. 41.7% of Beauty Health shares are held by insiders. Comparatively, 69.7% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Pulse Biosciences has lower revenue, but higher earnings than Beauty Health. Pulse Biosciences is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
Summary
Beauty Health beats Pulse Biosciences on 10 of the 17 factors compared between the two stocks.
Get Beauty Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beauty Health Competitors List
Related Companies and Tools
